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Neuropeptide S (NPS) exerts robust anxiolytic and memory enhancing effects, but only
in a non-social context. In order to study whether NPS affects aggressive behavior we
used Wistar rats bred for low (LAB) and high (HAB) levels of innate anxiety-related
behavior, respectively, which were both described to display increased levels of aggression
compared with Wistar rats not selectively bred for anxiety (NAB). Male LAB, HAB, and
NAB rats were tested for aggressive behavior toward a male intruder rat within their
home cage (10min, resident-intruder [RI] test). Intracerebroventricular (icv) infusion of NPS
(1 nmol) significantly reduced inter-male aggression in LAB rats, and tended to reduce
aggression in HAB and NAB males. However, local infusion of NPS (0.2 or 0.1 nmol
NPS) into either the nucleus accumbens or the lateral hypothalamus did not influence
aggressive behavior. Social investigation in the RI test and general social motivation
assessed in the social preference paradigm were not altered by icv NPS (1 nmol). The
anti-aggressive effect of NPS is most likely not causally linked to its anxiolytic properties,
as intraperitoneal administration of the anxiogenic drug pentylenetetrazole decreased
aggression in LAB rats whereas the anxiolytic drug diazepam did not affect aggression
in HAB rats. Thus, although NPS has so far only been shown to exert effects on non-social
behaviors, our results are the first demonstration of anti-aggressive effects of NPS in male
rats.
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INTRODUCTION
Aggressive behavior is an important pre-requisite for the acquisi-
tion and maintenance of feeding resources, territory and mating
partners and, therefore, for the survival of an individual and the
species. However, dysregulation of aggression among conspecifics
can lead to severe injury and death. Neuropeptides, like argi-
nine vasopressin and oxytocin, have been shown to be important
regulators of inter-male, female and maternal aggression (Ferris,
2005; Neumann and Landgraf, 2012; Calcagnoli et al., 2013; De
Jong et al., 2013), but are also part of neuronal circuits regulating
anxiety in rats and mice (Landgraf et al., 1995; McCarthy et al.,
1996; Bielsky et al., 2005; Blume et al., 2008). With respect to a
possible link between inter-male aggression and anxiety, studies
describe either an association between low levels of anxiety and
high levels of aggression (Nyberg et al., 2003; Beiderbeck et al.,
2007), or no such link (De Boer et al., 2003). In rats selectively
bred for extremes in innate anxiety, low anxiety-related behavior
(LAB) has been linked to high and abnormal inter-male aggres-
sion, but also male rats with high anxiety-related behavior (HAB)
show higher aggression levels compared with rats not selectively
bred for anxiety (NAB) (for review see Neumann et al., 2010).
Co-selection of factors regulating aggression along with those reg-
ulating both, low and high, anxiety-related behavior is likely to
underlie the behavioral phenotype of LAB and HAB rats.
The recently discovered neuropeptide S (NPS) exerts strong
anxiolytic effects in rats, including LAB and HAB rats, and mice,
when administered into the brain ventricles (icv), via the nasal
route (Xu et al., 2004; Ionescu et al., 2012; Lukas and Neumann,
2012; Slattery et al., 2012) and locally into the amygdala and the
hippocampus (Jüngling et al., 2008; Slattery et al., 2012; Dine
et al., 2013). NPS acts via specific G protein-coupled receptors
(NPSR) (Xu et al., 2004; Reinscheid et al., 2005), which are widely
localized within limbic and hypothalamic brain regions, whereas
NPS mRNA expression is restricted to a small population of neu-
rons between the locus coeruleus and the Barrington nucleus (Xu
et al., 2004; Leonard and Ring, 2011). In addition to its anx-
iolytic properties, NPS facilitates spatial learning and memory
in the Morris water maze (Han et al., 2009), the extinction of
aversive memories (Jüngling et al., 2008) as well as object recogni-
tion memory (Okamura et al., 2011; Lukas and Neumann, 2012).
However, the anxiolytic and memory enhancing effect of NPS
were exclusively seen in a non-social context, as neither social
anxiety in the social preference/social avoidance paradigm nor
social memory in the social discrimination test were altered by
NPS (Lukas and Neumann, 2012).
Furthermore, NPS was shown to inhibit reward and addic-
tion behaviors. Thus, NPS inhibits morphine-induced condi-
tioned place preference in mice (Li et al., 2009) and reduces
alcohol intake in an alcohol-preferring rat breeding line (Badia-
Elder et al., 2008). In this context it is of interest that the
high aggression of LAB rats is driven by an increased neu-
ronal activity in the nucleus accumbens (NAc), part of the
reward circuitry (Beiderbeck et al., 2012). High aggression in LAB
rats was also accompanied by an increased neuronal activation
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in hypothalamic subregions including the anterior and lateral
hypothalamus (LH) (Beiderbeck et al., 2012)—regions that are
also activated after icv NPS administration (Kallupi et al., 2010)
and express high levels of NPSR mRNA (Leonard and Ring,
2011). This makes NPS a promising candidate for reducing inter-
male aggression in highly aggressive individuals.
The primary aim of this study was, therefore, to investigate the
effect of NPS on inter-male aggression in LAB and HAB rats as
models of hyper-aggression, with non-selected (NAB) rats serv-
ing as low-aggressive controls. Additionally, we aimed to localize
the putative anti-aggressive effects of NPS in promising target
regions that are important in the regulation of both reward and
aggression, i.e., the NAc and LH. Finally, to investigate a putative
link between aggression and anxiety, we monitored inter-male
aggressive behavior after treatment with established anxiolytic or
anxiogenic agents.
MATERIALS AND METHODS
ANIMALS
Experiments were carried out on male Wistar rats either selec-
tively bred for low (LAB) and high (HAB) anxiety-related behav-
ior or non-selected rats (NAB) in the animal facilities of the
University of Regensburg (Neumann et al., 2010). Rats were
housed in groups of 4–6 under standard laboratory conditions
(12:12 h light/dark cycle with lights on at 06:00 h, 21 ± 1◦C,
60 ± 5% humidity, standard rat chow and water ad libitum).
For behavioral testing, adult resident LAB, HAB, and NAB
male rats (350–450 g) were each housed in an observation cage
(40 × 24 × 35 cm) together with a female Wistar rat (Charles
River, Sulzfeld, Germany) for 10 days (12:12 h light/dark cycle
with lights off at 12:00) to stimulate territorial behavior (Flannelly
and Lore, 1977; Beiderbeck et al., 2012). Bedding was not changed
during the last 3 days prior to the resident-intruder (RI) test. All
tests took place during the active phase starting 1 h after lights off,
i.e., between 13:00 and 15:00 h. The experiments were approved
by the Committee on Animal Health and Care of the Government
of the Oberpfalz.
INTRACEREBRAL IMPLANTATION OF GUIDE CANNULAS
For intracerebral drug infusion, guide cannulas were stereotaxi-
cally implanted either unilaterally 2mm above the lateral ven-
tricle or bilaterally 2mm above the NAc or the LH [relative
to bregma; icv: 1.0mm posterior, 1.6mm lateral, 2.0mm deep;
NAc: 1.7mm anterior, 1.6mm lateral, 4.6mm deep; LH: 1.8mm
posterior, 1.8mm lateral, 6.0mm deep; nose −3.5mm, (Paxinos
and Watson, 1998)]. Rats were anesthetized (Isoflurane, Forene®,
Abbott GmbH and Co. KG, Wiesbaden, Germany), injected
with an antibiotic (Baytril®, Bayer Vital GmbH, Leverkusen,
Germany), and mounted on a stereotaxic frame. The guide can-
nula (for icv: 21 G, 12mm; for NAc and LH: 23 G, 12mm;
Injecta GmbH, Germany) was fixed to the skull with two jeweler’s
screws and dental cement (Kallocryl, Speiko-Dr. Speier GmbH,
Muenster, Germany) and closed by a stainless steel stylet (25 G
and 27 G, respectively). Three days prior to and one day after
surgery, rats were handled (stroking, holding, cleaning of stylets)
for a total of 4 days to minimize non-specific stress responses
during the experiment.
INTRACEREBRAL DRUG APPLICATION
In order to study the effects of intracerebral NPS infusion, either
icv, or directly into the left and right NAc, or the left and right LH,
on aggression and social approach behavior, rats received either
synthetic NPS (icv: 1 nmol/5µl, i.e., 2µg/5µl; NAc/LH: 0.1 or
0.2 nmol/1µl, i.e., 0.2 or 0.1µg/1µl; H-6164; Bachem Holding
AG, Bubendorf, Switzerland) or vehicle (VEH, sterile Ringer’s
solution, pH 7.4, B. Braun Melsungen, Germany) via an infu-
sion cannula inserted into the guide cannula and connected to
a Hamilton syringe via polyethylene tubing. After icv or local
infusion, the cannula was left in place for 30 s. Infusions were
performed 30min prior to behavioral testing [RI test, elevated
pluz-maze (EPM), social preference test]. Doses and time points
for icv and local infusions were chosen based on their behavioral
effects in an emotional (EPM) and learning (object recognition)
context (Lukas and Neumann, 2012).
INTRAPERITONAL (ip) INJECTIONS
The anxiogenic drug pentylenetetrazole (PTZ; 25mg/kg; Sigma-
Aldrich, Steinheim, Germany) and the anxiolytic drug diazepam
(DIA; 2mg/kg; Ratiopharm, Ulm, Germany) or VEH were
injected ip 30min prior to behavioral testing on the EPM or in
the RI test. Based on Pellow et al. (1985) (20mg PTZ/kg 5min
before EPM) we tested a dose of 25mg/kg PTZ 30min before
EPM exposure in a pilot study in order to match the time point of
our other experiments; convulsive effects were not found in any
of the tested rats. To minimize unspecific stress responses due to
the injection, rats were handled daily during the early dark phase
starting 3 days prior to the experiment by gently placing the rat
in a dark tube (one end closed; length: 17 cm; diameter: 8 cm)
and touching their belly. As a result all rats went into the tube
voluntarily without signs of arousal or resistance.
BEHAVIORAL PARADIGMS
Resident-intruder (RI) test
For behavioral testing of male rats without prior surgery, the
female was removed from the resident’s cage 30min before the
beginning of the RI test. Otherwise, the female rat was removed
from the resident’s cage during surgery, and males were single-
housed in their experimental observation cage thereafter. At the
start of the 10-min RI test, an unfamiliar, non-aggressive, lighter
(10% less body weight) male Wistar rat (Charles River, Sulzfeld,
Germany) was placed into the cage of the resident.
The behavior of the resident was videotaped, and the fol-
lowing behaviors were scored by an experienced observer blind
to breeding line and treatment: aggressive behavior (attack, lat-
eral threat, offensive upright, keep down, threat, mounting,
aggressive grooming), social investigation (investigating oppo-
nent, anogenital sniffing), exploration, self-grooming, defensive
behavior, immobility and other behaviors like food intake or dig-
ging (Koolhaas et al., 1980; Beiderbeck et al., 2012). Behavior
was scored in real-time using pre-set computer keys (Eventlog;
Version 1.0, 1986, R. Hendersen).
Social preference test
The effects of icv NPS on social approach/social avoidance
behavior was studied using the social preference paradigm
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(Lukas et al., 2011). Briefly, rats were placed in a novel arena
(40 × 80 × 40 cm, red light), and after 30 s of habituation, an
empty wire-mesh cage (non-social stimulus; 20 × 9 × 9 cm) was
placed at one side wall of the arena for 4min. The empty cage was
then exchanged by an identical cage containing an unknown adult
male Wistar rat (social stimulus) for 4min. Exploration times of
the non-social and social stimulus (i.e., the time the rat spent in
active olfactory investigation) were scored by an observer blind
to the treatment using JWatcher behavioral observation software
(V 1.0, Macquarie University and UCLA). Data are presented as
the percentage of time investigating the non-social vs. the social
stimulus, i.e., investigation time/total time (4min) × 100. A sig-
nificantly higher percentage of mean investigation of the social vs.
the non-social stimulus within one group of rats was considered
social preference. Before each trial, the arena was cleaned with
water containing a low concentration of detergent.
Elevated plus-maze (EPM)
The effects of local (NAc, LH) NPS, ip PTZ and ip DIA on
non-social anxiety-related behavior was assessed using the EPM
(Pellow et al., 1985), which consisted of two opposing open (50 ×
10 cm, 100 lux) and two opposing closed arms (50 × 10 × 40 cm,
20 lux) connected by a central area (Beiderbeck et al., 2007).
Briefly, the EPM was made of dark gray plastics, elevated 80 cm
above the floor, and surrounded by an opaque curtain to avoid
external disturbance. Before each trial, the maze was cleaned with
water containing a low concentration of a detergent. The rat was
placed in the central area facing a closed arm. The percentage of
time spent on the open arms during the 5-min test (time on open
arms/time on open and in closed arms × 100) was assessed as
anxiety-related behavior, and the number of entries in the closed
arms as measurement for locomotion. Behavior was recorded by
means of a video camera mounted above the platform and scored
by a trained observer (Plus-maze version 2.0; E. Fricke).
EXPERIMENTAL DESIGN
By performing an initial RI test before beginning of all the experi-
ments, we confirmed that the level of aggression in both the future
vehicle and treatment groups did not differ.
EXPERIMENT 1: EFFECTS OF ICV NPS ON INTER-MALE AGGRESSION
AND GENERAL SOCIAL MOTIVATION
In order to study the effects of icv NPS on territorial aggres-
sion, groups of male LAB (n = 20), HAB (n = 20), and NAB
(n = 18) residents were infused icv with either NPS (1 nmol/5µl)
or VEH (Ringer’ solution) 30min prior to the RI test. To further
test for the specificity of NPS effects on aggressive behavior, the
general social motivation of several of these LAB (n = 19) and
HAB (n = 16) rats was tested in the social preference test 30min
after icv infusion of either NPS or VEH two days after the RI
test has been performed. Rats were infused with the identical icv
treatment received prior to the RI test.
EXPERIMENT 2: EFFECTS OF INFUSION OF NPS INTO THE NAC AND LH
OF LAB RATS
In order to localize the anti-aggressive effects of NPS, either NPS
(0.1 nmol/1µl, 0.2 nmol/1µl), or VEH were bilaterally infused
into the NAc (n = 18) or the LH (n = 46) of aggressive LAB
rats. Both brain regions were chosen based on high local NPSR
expression (Leonard and Ring, 2011) and an increase in neu-
ronal activation in response to the display of high aggression in
LAB rats (Beiderbeck et al., 2012). Three days later, several of
these rats (NAc, n = 18; LH, n = 22) were tested on the EPM for
anxiety-related behavior.
EXPERIMENT 3: EFFECTS OF ANXIOGENIC (PTZ) AND ANXIOLYTIC (DIA)
DRUGS ON INTER-MALE AGGRESSION
In order to study the effects of pharmacological manipulation of
anxiety-related behavior on aggression (Neumann et al., 2010),
LAB rats (n = 23) were injected with the anxiogenic drug PTZ
(25mg/kg, ip) (Cruz et al., 1994), HAB rats (n = 24) with the
anxiolytic drug DIA (2mg/kg, ip) (Pellow et al., 1985) and NAB
rats (n = 23) with both PTZ or DIA; respective controls received
VEH (Ringer’s solution, 1ml/kg; ip). Our pilot experiments (data
not shown) showed that the low anxiety-related behavior of male
LAB rats cannot be further reduced by DIA, thus, they were only
injected with PTZ. Similarly, the high anxiety level of HAB rats
cannot be further increased by PTZ; therefore, they were only
treated with DIA. Thirty min after the injection, the experimental
rats were tested for aggressive behavior in the RI test. Additional
groups of LAB (n = 12) and HAB (n = 16) males were treated
with PTZ or DIA, respectively, and their anxiety-related behavior
was tested on the EPM. The anxiolytic and anxiogenic effects of
DIA and PTZ, respectively, on the EPM in non-selected Wistar
rats are already very well established (Pellow et al., 1985; Cruz
et al., 1994).
HISTOLOGY
To verify the infusion sites, rats were killed by an overdose of anes-
thetics after the end of the behavioral tests. Icv brains were infused
via the guide cannula with ink (5µl), instantly cut coronally, and
checked for staining of the ventricle. Locally infused brains were
frozen in pre-chilled n-methylbutane on dry ice, and infusion sites
were localized on 40-µm coronal cryostat sections stained with
cresyl violet.
STATISTICS
All statistical analyses were performed using the software pack-
age SPSS (version 19). Behavioral parameters of the RI test
were analyzed using either Students t-test, when two treat-
ments were compared (e.g., vehicle vs. NPS, or vehicle vs.
PTZ) or a One-Way analysis of variance (ANOVA) followed
by a post-hoc analysis using Bonferroni correction, if appro-
priate, in case three treatments groups were compared (e.g.,
Vehicle, PTZ, DIA). If variance equality was violated, adjusted
p-values together with unadjusted degrees of freedom are pre-
sented with the t-values. Separate statistical analysis of treat-
ment effects as described above has been performed on LAB,
HAB, and NAB rats, as experiments on the 3 rat lines were
performed at different times. However, the parameter overall
aggressive behavior has been compared between all three lines
using a Two-Way ANOVA (factors rat line × treatment). Social
investigation in the social preference test was compared using a
2 × (2) mixed model ANOVA (drug treatment [between sub-
ject] × stimulus [within-subject]) followed by a post-hoc com-
parison using Bonferroni correction. EPM behavior was analyzed
Frontiers in Behavioral Neuroscience www.frontiersin.org May 2014 | Volume 8 | Article 185 | 3
Beiderbeck et al. Anti-aggresssive effects of neuropeptide S
using Student’s t-test. Data are presented as mean + standard
error of the mean (s.e.m.). Statistical significance was set at
p < 0.05.
RESULTS
EXPERIMENT 1: EFFECTS OF ICV NPS ON INTER-MALE AGGRESSION IN
LAB, HAB AND NAB MALES AND EFFECTS ON SOCIAL PREFERENCE IN
LAB AND HAB RATS
RI test
LAB rats treated with icv NPS (1 nmol) displayed less total
aggressive behavior [t(18) = 2.38; p < 0.05; Figure 1A] and spent
more time immobile (VEH: 3.9% ± 0.9, NPS: 12% ± 3.0)
[t(18) = −2.62; p < 0.05] in the RI test compared with VEH-
treated LABs. No significant differences between NPS- and
VEH-treated LAB residents were found in social investigation,
exploration or any other behavior investigated (Figure 1A).
There were no significant treatment effects on distinct aggressive
parameters.
In HAB rats, a trend toward reduced total aggressive behavior
[t(18) = 2.03; p = 0.057; Figure 1B], and an increase in immo-
bility (VEH: 4.9% ± 1.4, NPS: 28% ± 9.0) [t(18) = 2.59; p <
0.05; Table 1] were found after icv NPS-treatment compared
with VEH. No significant differences between NPS- and VEH-
treated rats were found with respect to social investigation and
exploration or any other behaviors investigated (Figure 1B).
NPS-treated NAB rats spent more time with cage exploration
[t(16) = −3.80; p < 0.01 vs. VEH], whereas social investigation,
aggressive behavior (Figure 1C) and immobility (data not shown)
did not significantly differ between the NAB treatment groups.
However, overall statistics of aggressive behavior on all three
strains, reveals a significant reduction of aggression betweenNPS-
and VEH-treated rats [F(1, 52) = 12.1; p < 0.005], indicating a
general anti-aggressive effect of NPS (Figure 1). Overall statistics
did not reveal an interaction effect [strain × treatment; F(2, 52) =
55.4; p = 0.685].
Social preference
In confirmation of previous results found in male NAB rats
(Lukas and Neumann, 2012), icv NPS did not alter social prefer-
ence behavior in LAB [F(1, 17) = 0.003; p = 0.96; Figure 2A] and
HAB [F(1, 13) = 0.004; p = 0.95; Figure 2B] rats as indicated by a
similar percentage of time exploring the social stimulus compared
with VEH-treated rats.
Whereas both VEH- (p < 0.01) as well as NPS-treated (p <
0.05) HAB males showed a preference for the social stimu-
lus compared to the non-social stimulus (Figure 2B), in con-
trast, social preference behavior was missing in LAB males
(Figure 2A).
EXPERIMENT 2: NO EFFECTS OF LOCAL INFUSIONS OF NPS INTO THE
NAC AND LH ON INTER-MALE AGGRESSION AND ANXIETY-RELATED
BEHAVIOR IN LAB RATS
RI test
Bilateral infusion of NPS into the NAc (VEH: 21% ± 5.5; NPS
[0.1 nmol]: 18% ± 2.3; NPS [0.2 nmol]: 15% ± 4.2) and the LH
(Vehicle: 55% ± 6.8; NPS [0.2 nmol]: 60% ± 5.1) did not change
total aggressive behavior.
FIGURE 1 | Behavior of LAB (A), HAB (B), and NAB (C) rats during the
RI test. NPS (1 nmol) was applied icv 30min before testing. Social
investigation, cage exploration, and aggressive behavior are calculated as
percentage of total time (10min). Numbers in parentheses indicate group
size. Date are means + s.e.m., ∗p < 0.05 vs. vehicle, (∗) 0.1 > p > 0.05.
Student’s t-test.
EPM
Similarly, LAB rats bilaterally infused with NPS (0.2 nmol) either
into the NAc or the LH did not differ from VEH-treated rats
in the percentage of time spent on the open arms of the EPM
(Table 1). Although there were no changes on home cage loco-
motion following NPS infusion into the LH in the RI test,
NPS infusion into the LH significantly increased the number
of entries in the closed arms [t(20) = −2.64; p < 0.05 vs. VEH;
Table 1].
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Table 1 | Anxiety-related behavior of LAB, HAB, and NAB rats on the elevated plus-maze (EPM) and home cage immobility during the resident-
intruder (RI) test.
Paradigm EPM RI (home cage)
Readout Time open arm (%) Entries closed arm Immobility (%)
Treatment Veh Drug Veh Drug Veh Drug
LAB (NPS/NAc) 69.2 ± 3.3 71.6 ± 5.4 6.5 ± 0.7 5.6 ± 0.8 7.2 ± 2.3 5.5 ± 1.0
LAB (NPS/LH) 65.3 ± 3.7 71.5 ± 4.9 4.6 ± 0.7 6.7 ± 0.5* 4.6 ± 1.0 6.8 ± 2.3
LAB (PTZ/ip) 76.1 ± 4.2 44.3 ± 6.2* 6.3 ± 0.9 5.3 ± 0.3 3.5 ± 0.67 9.3 ± 2.3*
HAB (DIA/ip) 3.2 ± 2.2 16.6 ± 6.0* 1.7 ± 0.7 2.6 ± 0.6 3.0 ± 0.82 9.2 ± 2.5*
Neuropeptide S (NPS, 0.2 nmol) was applied bilaterally in the nucleus accumbens (NAc) or the lateral hypothalamus (LH) 30min before testing. Pentylenetetrazol
(PTZ, 25mg/kg) and Diazepam (DIA, 2mg/kg) were injected ip, 30min before testing. Date are means ± s.e.m., *p < 0.05 vs. vehicle. Student’s t-test.
FIGURE 2 | Behavior of LAB (A) and HAB (B) rats in the social
preference test. NPS (1 nmol) or vehicle were applied icv 30min
before testing. Social preference was reflected by the time the
experimental rats spent sniffing the non-social (empty cage) and
the social stimulus, respectively. NPS (1 nmol) was applied icv
30min before testing. Time of non-social and social investigation
are calculated as percentage of total time (4min). Numbers in
parentheses indicate group size. Data are means + s.e.m.,
#p < 0.05 vs. non-social stimulus; 2 × (2) mixed model ANOVA
(drug treatment [between subject] × stimulus [within-subject])
followed by a post-hoc test (Bonferroni).
EXPERIMENT 3: EFFECTS OF IP PTZ AND DIA ON INTER-MALE
AGGRESSION AND ANXIETY-RELATED BEHAVIOR
RI test
LAB residents treated with the anxiogenic drug PTZ displayed
less inter-male aggression [t(21) = 5.72; p < 0.001] and social
investigation [t(21) = 2.48; p < 0.05], but more exploration
[t(21) = −5.21; p < 0.001; Figure 3A] and immobility [t(21) =
−2.41; p = 0.05; Table 1] compared with VEH-treated males.
In contrast, HAB males treated with the anxiogenic drug DIA
displayed more immobility [t(22) = −2.37; p < 0.05 vs. VEH;
Table 1], whereas aggression, social investigation and exploration
remained unchanged after DIA-treatment (Figure 3B).
In NAB residents treated with either PTZ, DIA or vehi-
cle (Figure 3C), there was no treatment effect on total aggres-
sion [F(2, 20) = 2.02; p = 0.16] or immobility [F(2, 20) = 0.90;
p = 0.42]. In contrast, there was a significant treatment effect
on social investigation [F(2, 20) = 4.35; p < 0.05] and exploration
[F(2, 20) = 18.3; p < 0.001]. In detail, PTZ-treated NAB males
spent more time with exploration (p < 0.001) than VEH- as well
as DIA-treated NAB rats (Figure 3C).
EPM
The established anxiogenic and anxiolytic effects of PTZ and DIA
(Pellow et al., 1985; Cruz et al., 1994) were confirmed in LAB
and HAB rats, respectively. PTZ-treated male LAB rats spent less
time on the open arms of the EPM [t(10) = 4.25; p < 0.01 vs.
VEH; Table 1] indicating an increase in anxiety-related behavior,
whereas the number of open arm entries remained unchanged.
In contrast, DIA-treated HAB rats showed increased time on the
open arms [t(14) = −2.31; p < 0.05 vs. VEH; Table 1] with an
unchanged number of open arm entries.
DISCUSSION
In the present study, we describe for the first time that central
NPS modulates social behavior in rats, as it reduces inter-male
aggression regardless of the innate aggression level. However,
attempts to localize the anti-aggressive effect of NPS in brain
regions involved in reward and aggression, namely the NAc
and the LH, failed suggesting that NPS may mediate these
effects in other brain regions or indirectly via modulation
of anxiety. In order to investigate the latter hypothesis, LAB,
HAB and NAB rats were treated with either established anx-
iogenic drug PTZ or the anxiolytics DIA (Pellow et al., 1985;
Cruz et al., 1994; Liebsch et al., 1998). Increasing anxiety in
male LAB rats via PTZ resulted in a reduction of aggressive
behavior accompanied by a reduction in social investigation,
whereas reducing anxiety in HAB rats via DIA did not affect
aggression.
Former studies have demonstrated potent properties of NPS
to reduce anxiety- and fear-related behavior (Xu et al., 2004;
Jüngling et al., 2008; Ionescu et al., 2012; Lukas and Neumann,
2012; Slattery et al., 2012; Dine et al., 2013), and to modu-
late learning and memory (Han et al., 2009; Okamura et al.,
2011; Lukas and Neumann, 2012) when applied either icv or
locally into the amygdala and ventral hippocampus in rats and
mice. In contrast, social behaviors including social approach,
social anxiety, and social memory were not altered by synthetic
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FIGURE 3 | Behavior of LAB (A), HAB (B), and NAB (C) rats during the
RI test. Pentylenetetrazol (PTZ, 25mg/kg) and Diazepam (DIA, 2mg/kg)
were applied ip 30min before testing. Social investigation, cage
exploration, and aggressive behavior are calculated as percentage of total
time (10min). Numbers in parentheses indicate group size. Date are means
+ s.e.m., ∗p < 0.05 vs. vehicle. One-Way-ANOVA followed by post-hoc test
(Bonferroni) and student’s t-test, respectively.
NPS, and the endogenous NPS system does not seem to con-
tribute to the regulation of these aspects of social behavior
(Lukas and Neumann, 2012). However, our findings provide
the first evidence for the involvement of NPS in the regula-
tion of inter-male aggression. The strongest anti-aggressive effect
of icv NPS was found in LAB rats, which show the highest
level of aggression. In contrast, the aggression-reducing effect
of NPS was less pronounced in HAB and NAB males, proba-
bly due to their generally lower level of aggression in the RI test
(Beiderbeck et al., 2012). Additionally, the aggression-reducing
effect of NPS could be based on the reduction of rewarding effects
of aggression, which were only found in LAB rats (Beiderbeck
et al., 2012). Further, differences in the endogenous NPS sys-
tem between LAB, HAB, and NAB rats have been demonstrated.
In particular, increased NPSR expression in LAB compared to
HAB males within the hypothalamic paraventricular nucleus
(PVN) of rats and the medial amygdala of mice (Slattery et al.,
2012) may begin to explain the differences observed in the
present study.
Importantly, the NPS-induced decrease in aggression is not
due to a general reduction in social motivation, as the time
rats spend in non-aggressive social investigation during the RI
test and social approach behavior in the social preference test
was not altered by NPS in any of the groups. These results are
in confirmation of our recent findings of NPS exerting anx-
iolytic (Slattery et al., 2012) and memory-enhancing (Lukas
and Neumann, 2012) effects only in a non-social context with-
out altering social preference behavior or social discrimination
abilities.
Former studies have repeatedly shown increased locomotion
and arousal after central NPS treatment, when testing was per-
formed in unknown, stressful environments or in the early light
phase (Xu et al., 2004; Smith et al., 2006; Rizzi et al., 2008).
In contrast, we found a significant increase in immobility after
icv NPS in both LAB and HAB rats during the RI test. This
may be a consequence of the reduced time these rats spent with
aggressive behavior. In our experiments, residents were tested
in their home cage during the early dark phase, i.e., the active
phase of rats, which may further explain the lack of arousal after
NPS-treatment.
In an attempt to identify the brain region(s) responsible for
the anti-aggressive effect of NPS we selected two regions, the NAc
and LH, characterized by both the presence of NPSRs (Leonard
and Ring, 2011) and by increased neuronal activity in response
to the display of high aggression in LAB residents (Beiderbeck
et al., 2012). In addition to the NAc and the LH, NPSRs were
identified in several brain regions belonging to the reward sys-
tem and in the hypothalamic part of the stress axis including
the ventral tegmental area and the arcuate hypothalamic nucleus,
as well as in other regions involved in the regulation of aggres-
sion like the anterior and dorsal hypothalamic area (Leonard
and Ring, 2011). Furthermore, the NAc was selected as a target
region as we have recently demonstrated that the high aggres-
sion level of LAB rats is mediated via the mesolimbic reward
system, i.e., the dopamine system in the NAc (Beiderbeck et al.,
2012). As NPS may directly act on brain regions known to be
important for the regulation of aggression, we also chose the
LH for local NPS infusions (Tulogdi et al., 2010). This was sup-
ported by the finding of Kallupi et al. (2010) demonstrating
that icv infusion of NPS triggers neuronal activation in the LH
in mice.
Although previously shown to exert local effects on anxi-
ety in other brain regions (Jüngling et al., 2008; Ionescu et al.,
2012; Slattery et al., 2012; Dine et al., 2013) bilateral infusion of
NPS into either the NAc or LH prior to behavioral testing did
not alter inter-male aggression in the RI test or anxiety-related
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behavior on the EPM. Although it cannot be excluded that
higher doses of NPS may be effective, this suggests that these
two regions are not mediating the anxiolytic and anti-aggressive
effects of NPS. Thus, further studies are needed to localize the
aggression-reducing effect of NPS. Potential target regions are
the anterior hypothalamus and the arcuate nucleus, which are
not only rich in NPSRs (Leonard and Ring, 2011), but also
implicated in the regulation of aggression (Veening et al., 2005;
Siever, 2008; Beiderbeck et al., 2012). Furthermore, the ven-
tral tegmental area, which is also rich of NPSRs and represents
the upstream element of the dopaminergic reward system, could
be a target for future studies, but local neuronal activation did
not increase during the display of high aggression in LAB rats
(Beiderbeck et al., 2012). Additionally, further studies should
investigate, whether infusion of NPS into regions involved in its
anxiolytic effect, like the amygdala or the ventral hippocampus
(Jüngling et al., 2008; Dine et al., 2013) also leads to a reduction
of aggression in male rats. Another option for indirect regulation
of aggression is that hypothalamic regions linked to the regula-
tion of hypothalamus-pituitary-adrenal (HPA) axis activity, for
example the PVN, may be of importance for the anti-aggressive
effects of NPS. Alterations in the reactivity of the HPA axis
to social stressors may also underlie behavioral changes in the
RI test. However, both high and low HPA axis reactivity have
been associated with high aggression levels (Haller and Kruk,
2006; Veenema et al., 2007; Neumann et al., 2010), resulting in
the hypothesis of reactive vs. non-reactive aggression (Koolhaas
et al., 1999). This opens the route for speculations that NPS
reduces aggression via modulating the HPA axis and thereby
the social stress response. However, HPA response after aggres-
sive encounters is already increased in highly aggressive LAB rats
(Veenema et al., 2007), and NPS is considered to result in a fur-
ther activation of the HPA axis; at least under basal conditions
(Smith et al., 2006).
Finally, we investigated whether the effect of NPS on aggres-
sion could be due to its robust anxiolytic properties. Thus, LAB
and HAB males were treated with established anxiogenic (PTZ)
and anxiolytic (DIA) substances prior to exposure to the RI test,
respectively. PTZ-treatment of LAB rats indeed increased their
low basal anxiety level, and reduced their high level of aggres-
sive behavior in the RI test compared with vehicle-treated LAB
males. Moreover, DIA-treatment of HAB rats resulted in reduced
anxiety levels as seen after NPS treatment, but did not alter
inter-male aggression. In NAB rats, neither PTZ nor DIA altered
their low level of aggression in the RI test. In the last years,
the potential link between aggression and anxiety has been dis-
cussed controversially (for review see Neumann et al., 2010).
Such a link has been shown, for example, in different strains
of mice (Cases et al., 1995; Oliveira-Dos-Santos et al., 2000;
Nyberg et al., 2003), whereas other studies did not find such a
link. For example, enkephalin knockout mice and North Carolina
mice show both increased inter-male aggression and increased
anxiety (Nehrenberg et al., 2009). In LAB and HAB rats, both
individuals with low and high innate anxiety levels are more
aggressive compared with NAB rats. However, LAB males display
not only the highest level, but also abnormal forms of aggression
(Beiderbeck et al., 2012). Additionally, mice bred for short- or
long-attack latency do not differ in anxiety-related behavior
(Hogg et al., 2000). Also, oxytocin knockout mice characterized
by low levels of anxiety do not consistently differ in aggression
compared with wild-type mice (Winslow et al., 2000). Thus, it
has been suggested that aggression and anxiety can be indepen-
dently regulated. In support, highly aggressive North Carolina
mice show a reduction in both aggression and anxiety when
treated with DIA (Nehrenberg et al., 2009), whereas the HAB
rats in the present study did not show a decrease in aggression
after DIA-treatment. Also, increasing anxiety-related behavior
by PTZ, and infusion of the anxiolytic NPS reduced aggression
in LAB rats. Taken together, there are multiple studies rather
suggesting lack of a direct link between and independent regu-
lation of aggression and anxiety. Therefore, the anti-aggressive
properties of NPS are not likely to be caused by its strong
anxiolytic effect.
In conclusion, central infusion of NPS is effective to reduce
inter-male aggression in rats, an effect which was not accompa-
nied by a reduction of social interaction or social preference. Our
experiments further suggest that the anti-aggressive effect of NPS
is independent of its anxiolytic action, as alterations in anxiety
may ormay not result in alterations in aggression. Thus, our study
is the first to identify the regulatory capacity of NPS to modify
social behavior.
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